{"product_id":"international-myeloma-society-myeloma-cure-summit-definitions-metrics-and-milestones-2026","title":"International Myeloma Society Myeloma Cure Summit Definitions, Metrics, and Milestones 2026","description":"\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003ch1 class=\"product_title entry-title\"\u003eInternational Myeloma Society Myeloma Cure Summit Definitions, Metrics, and Milestones 2026\u003c\/h1\u003e\r\n\u003cstrong\u003e+ Target Audience: Hematologists, Medical Oncologists, Immunologists, Radiologists\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-179\" data-path-to-node=\"2\"\u003e\u003cspan data-path-to-node=\"2,0\"\u003eThe Myeloma Cure Summit: Definitions, Metrics, and Milestones is an event scheduled for February 20-21, 2026, with locations noted as both Virtual and in Miami, FL\u003c\/span\u003e\u003cspan data-path-to-node=\"2,2\"\u003e. A central goal for this meeting is to establish a working consensus on the definition of “cure” in myeloma alongside international thought leaders on the disease\u003c\/span\u003e\u003cspan data-path-to-node=\"2,4\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\u003ch2 data-path-to-node=\"3\"\u003eLearning Objectives\u003c\/h2\u003e\r\n\u003cul data-path-to-node=\"4\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-180\" data-path-to-node=\"4,0,0\"\u003e\u003cspan data-path-to-node=\"4,0,0,0\"\u003eTo evaluate key parameters in myeloma, including the depth and durability of minimal residual disease (MRD) negativity\u003c\/span\u003e\u003cspan data-path-to-node=\"4,0,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-181\" data-path-to-node=\"4,1,0\"\u003e\u003cspan data-path-to-node=\"4,1,0,0\"\u003eTo assess the roles of advanced imaging and mass spectrometry in defining a cure\u003c\/span\u003e\u003cspan data-path-to-node=\"4,1,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-182\" data-path-to-node=\"4,2,0\"\u003e\u003cspan data-path-to-node=\"4,2,0,0\"\u003eTo understand immune reconstitution, time off therapy, and the restoration of normal function\u003c\/span\u003e\u003cspan data-path-to-node=\"4,2,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-183\" data-path-to-node=\"4,3,0\"\u003e\u003cspan data-path-to-node=\"4,3,0,0\"\u003eTo explore the potential reversion to an MGUS-like state under the guidance of leading investigators and clinicians\u003c\/span\u003e\u003cspan data-path-to-node=\"4,3,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-184\" data-path-to-node=\"4,4,0\"\u003e\u003cspan data-path-to-node=\"4,4,0,0\"\u003eTo review data from long-term follow-up studies globally to understand sustained outcomes\u003c\/span\u003e\u003cspan data-path-to-node=\"4,4,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-185\" data-path-to-node=\"4,5,0\"\u003e\u003cspan data-path-to-node=\"4,5,0,0\"\u003eTo examine patient sub-group considerations, such as age and disease risk, to determine who is most likely to be cured\u003c\/span\u003e\u003cspan data-path-to-node=\"4,5,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-186\" data-path-to-node=\"4,6,0\"\u003e\u003cspan data-path-to-node=\"4,6,0,0\"\u003eTo review the definitions of cure in other malignancies (e.g., testicular cancer, lymphomas, leukemias) and apply those lessons to myeloma\u003c\/span\u003e\u003cspan data-path-to-node=\"4,6,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-187\" data-path-to-node=\"4,7,0\"\u003e\u003cspan data-path-to-node=\"4,7,0,0\"\u003eTo identify specific therapies and concepts that are potentially able to increase cure fractions\u003c\/span\u003e\u003cspan data-path-to-node=\"4,7,0,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-path-to-node=\"5\"\u003eTarget Audience\u003c\/h2\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-188\" data-path-to-node=\"6\"\u003e\u003cspan data-path-to-node=\"6,0\"\u003eThe IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners\u003c\/span\u003e\u003cspan data-path-to-node=\"6,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"6\"\u003e\u003cspan data-path-to-node=\"6,2\"\u003eBest for Hematologists, Medical Oncologists, Immunologists, Radiologists, and Clinical Researchers.\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\u003ch2 data-path-to-node=\"7\"\u003eTopics\u003c\/h2\u003e\r\n\u003cp data-path-to-node=\"8\"\u003e\u003cb data-path-to-node=\"8\" data-index-in-node=\"0\"\u003eFebruary 20, 2026\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"9\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-189\" data-path-to-node=\"9,0,0\"\u003e\u003cspan data-path-to-node=\"9,0,0,0\"\u003e\u003cb data-path-to-node=\"9,0,0,0\" data-index-in-node=\"0\"\u003e7:00-8:00\u003c\/b\u003e | BREAKFAST\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-190\" data-path-to-node=\"9,1,0\"\u003e\u003cspan data-path-to-node=\"9,1,0,0\"\u003e\u003cb data-path-to-node=\"9,1,0,0\" data-index-in-node=\"0\"\u003e8:00-8:15\u003c\/b\u003e | INTRODUCTION: Nikhil Munshi, Vincent Rajkumar, Philippe Moreau\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-191\" data-path-to-node=\"9,2,0\"\u003e\u003cspan data-path-to-node=\"9,2,0,0\"\u003e\u003cb data-path-to-node=\"9,2,0,0\" data-index-in-node=\"0\"\u003e8:15-10:05 | SESSION 1: DATA FROM LONG TERM FOLLOW UP STUDIES PART I\u003c\/b\u003e (Chairs: Kenneth Anderson and Jesus San Miguel)\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"9,2,1\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-192\" data-path-to-node=\"9,2,1,0,0\"\u003e\u003cspan data-path-to-node=\"9,2,1,0,0,0\"\u003e\u003cb data-path-to-node=\"9,2,1,0,0,0\" data-index-in-node=\"0\"\u003e8:15-8:30\u003c\/b\u003e | IFM: Philippe Moreau and Xavier Leleu\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-193\" data-path-to-node=\"9,2,1,1,0\"\u003e\u003cspan data-path-to-node=\"9,2,1,1,0,0\"\u003e\u003cb data-path-to-node=\"9,2,1,1,0,0\" data-index-in-node=\"0\"\u003e8:30-8:45\u003c\/b\u003e | Spanish: Laura Rosinol\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-194\" data-path-to-node=\"9,2,1,2,0\"\u003e\u003cspan data-path-to-node=\"9,2,1,2,0,0\"\u003e\u003cb data-path-to-node=\"9,2,1,2,0,0\" data-index-in-node=\"0\"\u003e9:45-9:00\u003c\/b\u003e | Italian: Mario Boccadoro\u003c\/span\u003e\u003cspan data-path-to-node=\"9,2,1,2,0,2\"\u003e \u003ci data-path-to-node=\"9,2,1,2,0,2\" data-index-in-node=\"1\"\u003e(Note: Time provided exactly as in source)\u003c\/i\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-195\" data-path-to-node=\"9,2,1,3,0\"\u003e\u003cspan data-path-to-node=\"9,2,1,3,0,0\"\u003e\u003cb data-path-to-node=\"9,2,1,3,0,0\" data-index-in-node=\"0\"\u003e9:00-9:20\u003c\/b\u003e | HOVON and EMN: Pieter Sonneveld\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-196\" data-path-to-node=\"9,2,1,4,0\"\u003e\u003cspan data-path-to-node=\"9,2,1,4,0,0\"\u003e\u003cb data-path-to-node=\"9,2,1,4,0,0\" data-index-in-node=\"0\"\u003e9:20-9:35\u003c\/b\u003e | UK: Gordon Cook\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-197\" data-path-to-node=\"9,2,1,5,0\"\u003e\u003cspan data-path-to-node=\"9,2,1,5,0,0\"\u003e\u003cb data-path-to-node=\"9,2,1,5,0,0\" data-index-in-node=\"0\"\u003e9:35-9:50\u003c\/b\u003e | Greek: Meletios Dimopoulous\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-198\" data-path-to-node=\"9,2,1,6,0\"\u003e\u003cspan data-path-to-node=\"9,2,1,6,0,0\"\u003e\u003cb data-path-to-node=\"9,2,1,6,0,0\" data-index-in-node=\"0\"\u003e9:50-10:05\u003c\/b\u003e | German: Marc Raab\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-199\" data-path-to-node=\"9,3,0\"\u003e\u003cspan data-path-to-node=\"9,3,0,0\"\u003e\u003cb data-path-to-node=\"9,3,0,0\" data-index-in-node=\"0\"\u003e10:05-10:15\u003c\/b\u003e | BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-200\" data-path-to-node=\"9,4,0\"\u003e\u003cspan data-path-to-node=\"9,4,0,0\"\u003e\u003cb data-path-to-node=\"9,4,0,0\" data-index-in-node=\"0\"\u003e10:15-12:10 | SESSION 1: DATA FROM LONG TERM FOLLOW UP STUDIES PART II\u003c\/b\u003e (Chairs: Kenneth Anderson and Jesus San Miguel)\u003c\/span\u003e\u003cspan data-path-to-node=\"9,4,0,2\"\u003e \u003ci data-path-to-node=\"9,4,0,2\" data-index-in-node=\"1\"\u003e(Note: Listed as Part I in source text, but follows sequentially)\u003c\/i\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"9,4,1\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-201\" data-path-to-node=\"9,4,1,0,0\"\u003e\u003cspan data-path-to-node=\"9,4,1,0,0,0\"\u003e\u003cb data-path-to-node=\"9,4,1,0,0,0\" data-index-in-node=\"0\"\u003e10:15-10:30\u003c\/b\u003e | Arkansas: Samer Al Hadidi\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-202\" data-path-to-node=\"9,4,1,1,0\"\u003e\u003cspan data-path-to-node=\"9,4,1,1,0,0\"\u003e\u003cb data-path-to-node=\"9,4,1,1,0,0\" data-index-in-node=\"0\"\u003e10:30-10:45\u003c\/b\u003e | Mayo: Vincent Rajkumar\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-203\" data-path-to-node=\"9,4,1,2,0\"\u003e\u003cspan data-path-to-node=\"9,4,1,2,0,0\"\u003e\u003cb data-path-to-node=\"9,4,1,2,0,0\" data-index-in-node=\"0\"\u003e10:45-11:00\u003c\/b\u003e | ECOG SWOG: Shaji Kumar\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-204\" data-path-to-node=\"9,4,1,3,0\"\u003e\u003cspan data-path-to-node=\"9,4,1,3,0,0\"\u003e\u003cb data-path-to-node=\"9,4,1,3,0,0\" data-index-in-node=\"0\"\u003e11:00-11:15\u003c\/b\u003e | Industry Studies With Long Follow-up: Paul Richardson\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-205\" data-path-to-node=\"9,4,1,4,0\"\u003e\u003cspan data-path-to-node=\"9,4,1,4,0,0\"\u003e\u003cb data-path-to-node=\"9,4,1,4,0,0\" data-index-in-node=\"0\"\u003e11:15-11:30\u003c\/b\u003e | Allogenic Transplant: Sergio Giralt\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-206\" data-path-to-node=\"9,4,1,5,0\"\u003e\u003cspan data-path-to-node=\"9,4,1,5,0,0\"\u003e\u003cb data-path-to-node=\"9,4,1,5,0,0\" data-index-in-node=\"0\"\u003e11:30-12:10\u003c\/b\u003e | Discussion: Nizar Bahlis, Faith Davies, Joy Ho, Evangelos Terpos\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-207\" data-path-to-node=\"9,5,0\"\u003e\u003cspan data-path-to-node=\"9,5,0,0\"\u003e\u003cb data-path-to-node=\"9,5,0,0\" data-index-in-node=\"0\"\u003e12:10-1:00\u003c\/b\u003e | LUNCH\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-208\" data-path-to-node=\"9,6,0\"\u003e\u003cspan data-path-to-node=\"9,6,0,0\"\u003e\u003cb data-path-to-node=\"9,6,0,0\" data-index-in-node=\"0\"\u003e1:00-3:00 | SESSION 2: WHAT SHOULD BE CALLED A CURE DEFINITION\u003c\/b\u003e (Chairs: Nikhil Munshi and Philippe Moreau)\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"9,6,1\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-209\" data-path-to-node=\"9,6,1,0,0\"\u003e\u003cspan data-path-to-node=\"9,6,1,0,0,0\"\u003e\u003cb data-path-to-node=\"9,6,1,0,0,0\" data-index-in-node=\"0\"\u003e1:00-1:10\u003c\/b\u003e | Cure Fraction Models: What Does the Estimated Cure Fraction Really Mean?: John Crowley\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-210\" data-path-to-node=\"9,6,1,1,0\"\u003e\u003cspan data-path-to-node=\"9,6,1,1,0,0\"\u003e\u003cb data-path-to-node=\"9,6,1,1,0,0\" data-index-in-node=\"0\"\u003e1:10-1:20\u003c\/b\u003e | MRD Depth: Nikhil Munshi\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-211\" data-path-to-node=\"9,6,1,2,0\"\u003e\u003cspan data-path-to-node=\"9,6,1,2,0,0\"\u003e\u003cb data-path-to-node=\"9,6,1,2,0,0\" data-index-in-node=\"0\"\u003e1:20-1:30\u003c\/b\u003e | Imaging: Elena Zamagni\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-212\" data-path-to-node=\"9,6,1,3,0\"\u003e\u003cspan data-path-to-node=\"9,6,1,3,0,0\"\u003e\u003cb data-path-to-node=\"9,6,1,3,0,0\" data-index-in-node=\"0\"\u003e1:30-1:40\u003c\/b\u003e | Sustained With or Without Treatment: Noopur Raje\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-213\" data-path-to-node=\"9,6,1,4,0\"\u003e\u003cspan data-path-to-node=\"9,6,1,4,0,0\"\u003e\u003cb data-path-to-node=\"9,6,1,4,0,0\" data-index-in-node=\"0\"\u003e1:40-1:50\u003c\/b\u003e | Immune Reconstitution: Madhav Dhodapkar\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-214\" data-path-to-node=\"9,6,1,5,0\"\u003e\u003cspan data-path-to-node=\"9,6,1,5,0,0\"\u003e\u003cb data-path-to-node=\"9,6,1,5,0,0\" data-index-in-node=\"0\"\u003e1:50-2:00\u003c\/b\u003e | Off-Therapy Duration: Sundar Jagannath\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-215\" data-path-to-node=\"9,6,1,6,0\"\u003e\u003cspan data-path-to-node=\"9,6,1,6,0,0\"\u003e\u003cb data-path-to-node=\"9,6,1,6,0,0\" data-index-in-node=\"0\"\u003e2:00-2:10\u003c\/b\u003e | QOL – Return to Work Concept: Sonja Zweegman\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-216\" data-path-to-node=\"9,6,1,7,0\"\u003e\u003cspan data-path-to-node=\"9,6,1,7,0,0\"\u003e\u003cb data-path-to-node=\"9,6,1,7,0,0\" data-index-in-node=\"0\"\u003e2:10-2:20\u003c\/b\u003e | Attaining MGUS State: Maria-Victoria Mateos\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-217\" data-path-to-node=\"9,6,1,8,0\"\u003e\u003cspan data-path-to-node=\"9,6,1,8,0,0\"\u003e\u003cb data-path-to-node=\"9,6,1,8,0,0\" data-index-in-node=\"0\"\u003e2:20-3:00\u003c\/b\u003e | Discussion: Shaji Kumar\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-218\" data-path-to-node=\"9,7,0\"\u003e\u003cspan data-path-to-node=\"9,7,0,0\"\u003e\u003cb data-path-to-node=\"9,7,0,0\" data-index-in-node=\"0\"\u003e3:00-3:30\u003c\/b\u003e | BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-219\" data-path-to-node=\"9,8,0\"\u003e\u003cspan data-path-to-node=\"9,8,0,0\"\u003e\u003cb data-path-to-node=\"9,8,0,0\" data-index-in-node=\"0\"\u003e3:30-5:00 | SESSION 3: PATIENT SUB-GROUP CONSIDERATIONS WHO MAY BE CURABLE\u003c\/b\u003e (Chairs: David Avigan and Faith Davies)\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"9,8,1\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-220\" data-path-to-node=\"9,8,1,0,0\"\u003e\u003cspan data-path-to-node=\"9,8,1,0,0,0\"\u003e\u003cb data-path-to-node=\"9,8,1,0,0,0\" data-index-in-node=\"0\"\u003e3:30-3:40\u003c\/b\u003e | Age Groups: Are Young More Likely to be Cured?: Charlotte Pawlyn\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-221\" data-path-to-node=\"9,8,1,1,0\"\u003e\u003cspan data-path-to-node=\"9,8,1,1,0,0\"\u003e\u003cb data-path-to-node=\"9,8,1,1,0,0\" data-index-in-node=\"0\"\u003e3:40-3:50\u003c\/b\u003e | Disease Risk Considerations: HR vs SR Which One is More Curable?: Katja Weisel\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-222\" data-path-to-node=\"9,8,1,2,0\"\u003e\u003cspan data-path-to-node=\"9,8,1,2,0,0\"\u003e\u003cb data-path-to-node=\"9,8,1,2,0,0\" data-index-in-node=\"0\"\u003e3:50-4:00\u003c\/b\u003e | Administration of the Types of Therapy: Do We Need Cytotoxic Agents for Cure?: Saad Usmani\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-223\" data-path-to-node=\"9,8,1,3,0\"\u003e\u003cspan data-path-to-node=\"9,8,1,3,0,0\"\u003e\u003cb data-path-to-node=\"9,8,1,3,0,0\" data-index-in-node=\"0\"\u003e4:00-4:10\u003c\/b\u003e | Genomic Correlates of Cure?: Mehmet Samur\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-224\" data-path-to-node=\"9,8,1,4,0\"\u003e\u003cspan data-path-to-node=\"9,8,1,4,0,0\"\u003e\u003cb data-path-to-node=\"9,8,1,4,0,0\" data-index-in-node=\"0\"\u003e4:10-5:00\u003c\/b\u003e | Discussion: Niccolo Bolli, Robert Orlowski, Surbhi Sidana, Raphael Szalat\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-225\" data-path-to-node=\"9,9,0\"\u003e\u003cspan data-path-to-node=\"9,9,0,0\"\u003e\u003cb data-path-to-node=\"9,9,0,0\" data-index-in-node=\"0\"\u003e5:00-6:00 | SESSION 4: PATIENT VOICES\u003c\/b\u003e (Chairs: Vania Hungria and Ravi Vij)\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"9,9,1\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-226\" data-path-to-node=\"9,9,1,0,0\"\u003e\u003cspan data-path-to-node=\"9,9,1,0,0,0\"\u003e\u003cb data-path-to-node=\"9,9,1,0,0,0\" data-index-in-node=\"0\"\u003e5:00-5:15\u003c\/b\u003e | A Patient Who is Cured: Chris Bingaman\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-227\" data-path-to-node=\"9,9,1,1,0\"\u003e\u003cspan data-path-to-node=\"9,9,1,1,0,0\"\u003e\u003cb data-path-to-node=\"9,9,1,1,0,0\" data-index-in-node=\"0\"\u003e5:15-5:30\u003c\/b\u003e | What Does it Mean to be Considered Cured?: Anne Stovell\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-228\" data-path-to-node=\"9,9,1,2,0\"\u003e\u003cspan data-path-to-node=\"9,9,1,2,0,0\"\u003e\u003cb data-path-to-node=\"9,9,1,2,0,0\" data-index-in-node=\"0\"\u003e5:30-6:00\u003c\/b\u003e | Discussion: Adam Cohen, Francesca Gay, Ola Landgren, Paola Neri\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"10\"\u003e\u003cb data-path-to-node=\"10\" data-index-in-node=\"0\"\u003eFebruary 21, 2026\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"11\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-229\" data-path-to-node=\"11,0,0\"\u003e\u003cspan data-path-to-node=\"11,0,0,0\"\u003e\u003cb data-path-to-node=\"11,0,0,0\" data-index-in-node=\"0\"\u003e7:30-8:30\u003c\/b\u003e | BREAKFAST\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-230\" data-path-to-node=\"11,1,0\"\u003e\u003cspan data-path-to-node=\"11,1,0,0\"\u003e\u003cb data-path-to-node=\"11,1,0,0\" data-index-in-node=\"0\"\u003e8:30-10:35 | SESSION 5: REVIEW OF CURATIVE MALIGNANCIES – HOW DID THEY ACHIEVE CURE? WHAT IS THEIR DEFINITION?\u003c\/b\u003e (Chairs: Kenneth Anderson and Patrick Loehrer)\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"11,1,1\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-231\" data-path-to-node=\"11,1,1,0,0\"\u003e\u003cspan data-path-to-node=\"11,1,1,0,0,0\"\u003e\u003cb data-path-to-node=\"11,1,1,0,0,0\" data-index-in-node=\"0\"\u003e8:30-8:50\u003c\/b\u003e | Testicular Cancer and Therapy De-escalation in Curative Cancer: Patrick Loehrer\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-232\" data-path-to-node=\"11,1,1,1,0\"\u003e\u003cspan data-path-to-node=\"11,1,1,1,0,0\"\u003e\u003cb data-path-to-node=\"11,1,1,1,0,0\" data-index-in-node=\"0\"\u003e8:50-9:05\u003c\/b\u003e | High Grade B-cell Lymphoma: James Armitage\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-233\" data-path-to-node=\"11,1,1,2,0\"\u003e\u003cspan data-path-to-node=\"11,1,1,2,0,0\"\u003e\u003cb data-path-to-node=\"11,1,1,2,0,0\" data-index-in-node=\"0\"\u003e9:05-9:25\u003c\/b\u003e | Cure of Most Leukemias: Hagop Kantarjian\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-234\" data-path-to-node=\"11,1,1,3,0\"\u003e\u003cspan data-path-to-node=\"11,1,1,3,0,0\"\u003e\u003cb data-path-to-node=\"11,1,1,3,0,0\" data-index-in-node=\"0\"\u003e9:25-9:40\u003c\/b\u003e | Cure in Hodgkin’s Disease: Peter Borchmann\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-235\" data-path-to-node=\"11,1,1,4,0\"\u003e\u003cspan data-path-to-node=\"11,1,1,4,0,0\"\u003e\u003cb data-path-to-node=\"11,1,1,4,0,0\" data-index-in-node=\"0\"\u003e9:40-9:50\u003c\/b\u003e | Colon Cancer – Off Therapy: Time to Define Cure: Alberto Sobrero\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-236\" data-path-to-node=\"11,1,1,5,0\"\u003e\u003cspan data-path-to-node=\"11,1,1,5,0,0\"\u003e\u003cb data-path-to-node=\"11,1,1,5,0,0\" data-index-in-node=\"0\"\u003e9:50-10:35\u003c\/b\u003e | Discussion: Gareth Morgan, Adam Sperling, Amrita Krishnan, Uday Yanamandra\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-237\" data-path-to-node=\"11,2,0\"\u003e\u003cspan data-path-to-node=\"11,2,0,0\"\u003e\u003cb data-path-to-node=\"11,2,0,0\" data-index-in-node=\"0\"\u003e10:35-11:05\u003c\/b\u003e | BREAK\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-238\" data-path-to-node=\"11,3,0\"\u003e\u003cspan data-path-to-node=\"11,3,0,0\"\u003e\u003cb data-path-to-node=\"11,3,0,0\" data-index-in-node=\"0\"\u003e11:05-1:15 | SESSION 6: WHAT THERAPIES MAY LEAD TO A CURE: STUDIES AND THERAPIES THAT ARE POTENTIALLY ABLE TO INCREASE CURE FRACTIONS\u003c\/b\u003e (Chairs: Shaji Kumar and Maria-Victoria Mateos)\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"11,3,1\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-239\" data-path-to-node=\"11,3,1,0,0\"\u003e\u003cspan data-path-to-node=\"11,3,1,0,0,0\"\u003e\u003cb data-path-to-node=\"11,3,1,0,0,0\" data-index-in-node=\"0\"\u003e11:05-11:20\u003c\/b\u003e | Cure Concept 1: Sagar Lonial\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-240\" data-path-to-node=\"11,3,1,1,0\"\u003e\u003cspan data-path-to-node=\"11,3,1,1,0,0\"\u003e\u003cb data-path-to-node=\"11,3,1,1,0,0\" data-index-in-node=\"0\"\u003e11:20-11:35\u003c\/b\u003e | Cure Concept 2: Hermann Einsele\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-241\" data-path-to-node=\"11,3,1,2,0\"\u003e\u003cspan data-path-to-node=\"11,3,1,2,0,0\"\u003e\u003cb data-path-to-node=\"11,3,1,2,0,0\" data-index-in-node=\"0\"\u003e11:35-11:50\u003c\/b\u003e | Cure Concept 3: Ajai Chari\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-242\" data-path-to-node=\"11,3,1,3,0\"\u003e\u003cspan data-path-to-node=\"11,3,1,3,0,0\"\u003e\u003cb data-path-to-node=\"11,3,1,3,0,0\" data-index-in-node=\"0\"\u003e11:50-12:05\u003c\/b\u003e | Cure Concept 4: Niels van de Donk\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-243\" data-path-to-node=\"11,3,1,4,0\"\u003e\u003cspan data-path-to-node=\"11,3,1,4,0,0\"\u003e\u003cb data-path-to-node=\"11,3,1,4,0,0\" data-index-in-node=\"0\"\u003e12:05-12:20\u003c\/b\u003e | Cure Concept 5 – Early Intervention: Irene Ghobrial\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-244\" data-path-to-node=\"11,3,1,5,0\"\u003e\u003cspan data-path-to-node=\"11,3,1,5,0,0\"\u003e\u003cb data-path-to-node=\"11,3,1,5,0,0\" data-index-in-node=\"0\"\u003e12:20-1:15\u003c\/b\u003e | Discussion: Xavier Leleu, Ajay Nooka, Fredrik Schjesvold\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-245\" data-path-to-node=\"11,4,0\"\u003e\u003cspan data-path-to-node=\"11,4,0,0\"\u003e\u003cb data-path-to-node=\"11,4,0,0\" data-index-in-node=\"0\"\u003e1:15-2:30\u003c\/b\u003e | LUNCH\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"11,5,0\"\u003e\u003cb data-path-to-node=\"11,5,0\" data-index-in-node=\"0\"\u003e2:30-3:30 | SESSION 7: CONSENSUS CONSIDERATION AND FUTURE STUDIES TO FURTHER REFINE CURE\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"11,5,2\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a7e3c8d62dfc78db-247\" data-path-to-node=\"11,5,2,0,0\"\u003e\u003cspan data-path-to-node=\"11,5,2,0,0,0\"\u003ePanel\/Participants: Kenneth Anderson, Shaji Kumar, Maria-Victoria Mateos, Nikhil Munshi, Philippe Moreau, Noopur Raje, Jesus San Miguel\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Meducourse","offers":[{"title":"Default Title","offer_id":43113249833058,"sku":"MED-AMB09597","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/International-Myeloma-Society-Myeloma-Cure-Summit-Definitions-Metrics-and-Milestones-2026.jpg?v=1783964507","url":"https:\/\/meducourse.com\/products\/international-myeloma-society-myeloma-cure-summit-definitions-metrics-and-milestones-2026","provider":"Meducourse","version":"1.0","type":"link"}